AustralianSuper Pty Ltd
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1694164
MELBOURNE, C3
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,506,085
+$152,176 QoQ
Shares Held
3,032
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#750
of 1,745 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AustralianSuper Pty Ltd holds $157,332,349 across 6 Biotechnology names. VRTX ranks #4 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,196,491 | $135,634,219 | |
| 2 | ARGX |
Argenx SE
|
11,380 | $10,558,022 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
30,335 | $7,425,097 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,032 | $1,506,085 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,803 | $1,445,847 | |
| 6 | INSM |
INSMED Inc
|
7,157 | $763,079 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,506,085 | 3,032 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,353,909 | 3,032 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,374,587 | 3,032 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,187,452 | 3,032 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $22,819,171 | 51,256 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $62,029,325 | 127,943 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $88,221,502 | 219,075 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $105,282,019 | 226,374 | Shares | Sole | 2024-10-28 | |
| 2024-03-31 | $4,782,452 | 11,441 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $4,209,683 | 10,346 | Shares | Sole | 2024-01-16 | |
| No filing history on record for this holder in this stock. | ||||||